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Previous research identified veterinary clinics as hotspots with respect to accumulation
and spread of multidrug resistant extended-spectrum β-lactamase (ESBL)-producing
Escherichia coli (EC). Therefore, promoting the prudent use of antibiotics to decrease
selective pressure in that particular clinical environment is preferable to enhance
biosecurity for animal patients and hospital staff. Accordingly, this study comparatively
investigated the impact of two distinct perioperative antibiotic prophylaxis (PAP)
regimens (short-term versus prolonged) on ESBL-EC carriage of horses subjected to
colic surgery. While all horses received a combination of penicillin/gentamicin (P/G) as
PAP, they were assigned to either the “single-shot group” (SSG) or the conventional
“5-day group” (5DG). Fecal samples collected on arrival (t0), on the 3rd (t1) and on
the 10th day after surgery (t2) were screened for ESBL-EC. All isolates were further
investigated using whole genome sequences. In total, 81 of 98 horses met the inclusion
criteria for this study. ESBL-EC identified in samples available at t0, t1 and t2 were
4.8% (SSG) and 9.7% (5DG), 37% (SSG) and 47.2% (5DG) as well as 55.6% (SSG)
and 56.8% (5DG), respectively. Regardless of the P/G PAP regimen, horses were
9.12 times (95% CI 2.79–29.7) more likely to carry ESBL-EC at t1 compared to t0
(p < 0.001) and 15.64 times (95% CI 4.57–53.55) more likely to carry ESBL-EC at
t2 compared to t0 (p < 0.001). ESBL-EC belonging to sequence type (ST) 10, ST86,
ST641, and ST410 were the most prevalent lineages, with blaCTX−M−1 (60%) being the
dominant ESBL gene. A close spatio-temporal relationship between isolates sharing
a particular ST was revealed by genome analysis, strongly indicating local spread.
Consequently, hospitalization itself has a strong impact on ESBL-EC isolation rates
in horses, possibly masking differences between distinct PAP regimens. The results
of this study reveal accumulation and spread of multi-drug resistant ESBL-EC among
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horses subjected to colic surgery with different P/G PAP regimens, challenging the local
hygiene management system and work-place safety of veterinary staff. Moreover, the
predominance of particular ESBL-EC lineages in clinics providing health care for horses
needs further investigation.
Keywords: horse, ESBL, Escherichia coli, antibiotic resistance, multidrug resistant, spread
INTRODUCTION
The occurrence of zoonotic and multidrug resistant (MDR)
pathogens, such as methicillin resistant Staphylococcus aureus
(MRSA), Acinetobacter spp. and extended-spectrum β-lactamase
(ESBL)-producing Enterobacterales, are an ongoing challenge to
both, biosecurity and hygiene in veterinary clinics (Walther et al.,
2017, 2018a; Royden et al., 2019). Previous studies reported the
constant admission of equine patients carrying ESBL-producing
Escherichia coli (ESBL-EC) to horse clinics (Apostolakos et al.,
2017; Walther et al., 2018b). Moreover, hospital associated
infections (HAI) have been linked to local spread of the above-
mentioned MDR pathogens in horse clinics (Walther et al.,
2014b; van Spijk et al., 2019). These infections are often
difficult to handle due to a multitude of additional antimicrobial
resistances (AMR) commonly associated with ESBL-EC (Wieler
et al., 2011). In recent years, reports on ESBL-EC carriage
and fecal shedding in horses have increased (de Lagarde et al.,
2019; Hordijk et al., 2020). Hospital stay alone, for instance,
as well as antibiotic courses have only recently been identified
as important risk factors for ESBL-EC colonization of equine
patients (Schoster et al., 2020).
So far, knowledge on ESBL-EC isolation rates and local
dynamics considering particular equine patient groups, i.e.,
hospitalized horses subjected to colic surgery, is scarce.
A combination of penicillin and gentamicin (P/G) is among
the most common medications for perioperative antibiotic
prophylaxis (PAP) in horse surgery, including operative
abdominal (colic) interventions (Dallap Schaer et al., 2012;
Teschner et al., 2015). While different guidelines for antibiotic
administration in horses strongly suggest to abstain from PAP
prolongation beyond 24 h after elective interventions (Weese
et al., 2008; Swedish Veterinary Association, 2013), horses
subjected to abdominal surgery seem to commonly receive the
P/G combination for 5 days afterward (Teschner et al., 2015). In
a previous study, reduction of the P/G PAP to 72 h (3 days) after
surgery showed no significant influence on the clinical outcome
of the equine patients (Dallap Schaer et al., 2012). However,
the putative effect of decreased selective (antibiotic) pressure
on the local MDR pathogen load, especially ESBL-EC, was not
investigated in the mentioned study.
This study was carried out within an interdisciplinary
research network (Köck et al., 2020) investigating strategies to
enhance the prudent use of antibiotics in veterinary medicine.
Accordingly, the aims were (i) to assess ESBL-EC phenotypes
and isolation rates in hospitalized horses, (ii) to investigate
whether a short-term or a prolonged P/G PAP influences these
rates, and (iii) to identify potential ESBL-EC transmission events
and local dynamics.
MATERIALS AND METHODS
Ethics and Study Outline
According to the German regulation authorities for research with
animal subjects, the comparison of two PAP regimens does not
require approval (Landesamt für Gesundheit und Soziales, Berlin,
18.04.2017). Written owner’s consent with respect to involvement
of their horses in the study was obtained directly during the
hospital admission process.
Here, we have comparatively investigated the effect of two
distinct PAP regimes on isolation rates of ESBL-EC from
specimens of horses subjected to colic surgery. A graphical
abstract of the study design is provided in Figure 1. Horses
included in this study were assigned per lot (sealed envelope
drawn at the day of surgery) to one of two groups: the “5-
day group” (5DG) which received a combination of penicillin
(22,000 IU/kg q 6 h) and gentamicin (6.6 mg/kg q 24 h) (short:
P/G) (Dallap Schaer et al., 2012; Teschner et al., 2015) for 5
days and the “single-shot group” (SSG), which received P/G
PAP only directly before, and, if necessary due to prolonged
surgery- also during the elective procedure Briefly, horses
considered as study participants needed to be older than 1
year, had to be clear of any clinical signs of infectious diseases
before the intervention and had to recover from anaesthesia
(“stand up”) after surgery. Furthermore, equine patients were
excluded from further participation (i.e., consideration of
specimens at t1 and/or t2; Figure 1) when their hospital stay
ended prematurely due to euthanasia (premature), discharge
and/or if the antibiotic regime they had been assigned to
was no longer strictly followed, regardless of the particular
reasons for these interventions. In consequence, the number
of valid specimens available per time point shrank toward the
end of the study.
Sample Collection
In order to investigate ESBL-EC rates in specimens from
the equine patients, fecal samples and nostril swabs (Copan
Liquid Amies Elution Swab, flocked) were directly collected
from each horse at the time of hospital admission (t0) as
described previously (Walther et al., 2018b). A second and a
third sampling was carried out on day three (t1) and ten (t2)
after surgery (Figure 1). All specimens were stored at 4◦C
and subjected to microbiological diagnostics latest on the next
day. We included the nostril sampling in this study, since
dust particles containing ESBL-EC have been reported as a
potential source of contamination and, possibly, colonization in
farmers exposed to an environment prone to MDR pathogens
(Fischer et al., 2017).
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FIGURE 1 | Graphical abstract of the prospective study. Horses were assigned to either the “single-shot group” (SSG) or the “5-day group” (5DG) per lot (sealed
envelope drawn directly at hospital admission). Fecal samples and nostril swabs were collected at t0 (hospital admission), t1 (3 days after surgery) and t2 (10 days
after surgery). All samples were screened for putative ESBL-EC, subjected to the confirmatory testing followed by AST and whole genome sequencing.
Bacterial Identification and Antimicrobial
Susceptibility Testing
All fecal samples and nostril swabs were initially cultured
on Brilliance
TM
ESBL Agar plates (Thermo Scientific
TM
,
Germany) overnight. Colonies showing characteristic growth
signatures of ESBL-EC on chromogenic screening plates
were further investigated. In case of distinct phenotype
appearances of presumptive EC growing on the plates,
all isolates were subjected to the ESBL confirmatory test
according to the Clinical and Laboratory Standards Institute
(CLSI) recommendations (Clinical and Laboratory Standards
Institute [CLSI], 2018). Additionally, disk diffusion method
was performed to detect putative plasmidal AmpC (pAmpC)-
producers using cefoxitin (30 µ) with a ≤18 mm screening
cut-off (Polsfuss et al., 2011). Species confirmation was
achieved by Matrix-Assisted Laser Desorption/Ionization-
Time Of Flight (MALDI-TOF) mass spectrometry (Bruker,
Germany). The Vitek2 AST-GN38 and AST-GN 96 cards
(bioMérieux, Germany) were used for antimicrobial
susceptibility testing (AST) on the VITEK R©2 system (BioMérieux,
Germany) including enrofloxacin, gentamicin, trimethoprim-
sulfamethoxazole and tetracycline following CLSI standards
(Clinical and Laboratory Standards Institute [CLSI], 2020).
Whole Genome Sequencing,
Antimicrobial Resistance Gene Detection
and Phylogenetic Relationship of the
Isolates
DNA isolation was performed for all confirmed ESBL/pAmpC-
EC with the QIAamp R© DNA Mini Kit (250) (Qiagen,
United States) and the respective DNA was subsequently
stored at −20◦C. Whole genome sequencing (WGS) was
performed using Illumina MiSeq 250 bp paired-end sequencing
with an obtained coverage >80. After adapter trimming, 247.9 bp
remained on average per read. Illumina raw read data sequenced
for this study is available at National Center for Biotechnology
Information (NCBI) under Bioproject ID: PRJNA698802.
Assembled draft genomes of the isolates were obtained from
SPAdes v.3.13.1 (Bankevich et al., 2012) and annotated with
Prokka v.1.14.6 (Seemann, 2014). WGS data were used for
the determination of the sequence type (ST) and resistance
genes (threshold: 98% ID, 90% minimum query coverage)
performed by Center for Genomic Epidemiology (Bortolaia et al.,
2020). PlasmidFinder and pMLST v.1.3 pipelines were used for
the identification of plasmids associated with Enterobacteriales
(Zankari et al., 2012; Carattoli et al., 2014). A core genome
alignment was calculated using Roary v.3.13.0 (Page et al., 2015),
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with a minimum sequence identity of 95%. The alignment was
used to construct a maximum likelihood-based phylogeny with
RAxML v.8.2.10 (Stamatakis, 2014) and 100 bootstraps under the
assumption of the gtr-gamma DNA substitution model.
In order to investigate potential MDR pathogen transmission
events within the horse clinic, pairwise single-nucleotide
polymorphism (SNP) distances were calculated with snp-dists
v.0.7.01 and visualized using the R package “pheatmap”2.
Furthermore, pairwise SNP distances were utilized to identify
clonally related ESBL-EC genomes for each of the major sequence
type complexes (STC) identified (Supplementary Figures 1–3).
Since the mutation rate for ESBL-EC genomes was estimated to
be 4.14 × 10−7 SNPs per site per year (Ludden et al., 2020), a
clonal relationship was defined conservatively as isolates with five
or fewer SNPs between any two members of a group, as reported
previously (D’Souza et al., 2019).
Statistical Analysis
Statistical analyses were conducted using the SPSS software
(Statistical Package of Social Science, version 26.0, Chicago,
IL, United States). The comparative analysis of the proportion
of ESBL-EC positive equine patients was performed using the
McNemar test for categorial variables and by analyzing the
proportions of ESBL-positive fecal samples at two sampling time
points (t0 and t1) or (t0 and t2). Generalized estimating equation
(GEE) analysis for clustered binomial responses was used to
determine the effect of hospitalization (t1 and t2), different
P/G PAP regimes (short-term or prolonged), and a potential
interaction effect, on the occurrence of ESBL-EC in fecal samples
of horses subjected to colic surgery. A p-value of < 0.05 was
considered statistically significant.
RESULTS
Study Population and Sample Acquisition
A total of 98 horses subjected to abdominal surgery due to
acute abdomen (colic) from January 2018 to February 2020 have
been considered as study participants. However, only 81 of these
horses met the inclusion criteria for this study at t0, with n = 32
belonging to the SSG and n = 49 to the 5DG (Figure 2). Due to the
medical nature of colic syndrome, which is often accompanied
by defecation disorders, samples were not available for all horses
at all sampling times, as indicated by the numbers associated
with the sample symbols in Figure 2. Moreover, until the end
of the study, samples from five horses belonging to the SSG and
12 from the 5DG were excluded from further evaluation—the
reasons included sudden discharge, euthanasia due to animal
welfare or deviation from the antibiotic protocol. In addition,
temporary unavailability of Benzylpenicillin for veterinary use
caused premature termination of the study in 02/2020. This event
lead to a restricted number of study participants and therefore
also limited the representativeness of the study outcome.
1https://github.com/tseemann/snp-dists
2https://github.com/raivokolde/pheatmap
Isolation Rates of ESBL-EC in
Specimens of Equine Patients Subjected
to Colic Surgery Receiving Different
Regimes of P/G PAP
Considering the isolation rates for each sampling point, ESBL-EC
were occasionally identified in nostril swabs obtained from both
horse groups investigated (Figure 2 and Supplementary Table 1).
In total, 2/87 (2%) nostril swabs obtained from the SSG and 8/129
(6%) of the 5DG were ESBL-EC positive.
In the SSG, 1/21 (4.8%) fecal samples collected at the time
of hospital admission (t0) were positive for ESBL-EC, while the
isolation rate increased to 10/27 (37%) at t1. At the tenth day of
hospital stay, 15/27 (55.6%) of the SSG fecal samples were positive
for ESBL-EC (p = 0.003). The ESBL-EC rate among samples from
horses belonging to the 5DG was 3/31 (9.7%) at t0 and increased
to 17/36 (47.2%) at t1. At t2 (i.e., the tenth day after surgery
and the fifth day after the last antibiotic course), 21/37 (56.8%)
fecal samples were ESBL-EC positive (p = 0.013; Figure 2).
There were no statistically significant differences between the
proportions of ESBL-EC positive fecal samples of the two study
groups investigated (Figure 2). Regardless of the P/G PAP regime,
horses were 9.12 times (95% CI 2.79–29.7) more likely to carry
ESBL-EC at t1 compared to t0 (p < 0.001) and 15.64 times (95%
CI 4.57–53.55) more likely to carry ESBL-EC at t2 compared to t0
(p < 0.001).
Antibiotic Susceptibility Profiles and
Antimicrobial Resistance Genes
AST results for the most common antibiotics in equine medicine
(enrofloxacin, gentamicin, trimethoprim-sulfamethoxazole and
tetracycline) obtained for 85 ESBL-EC are shown in Table 1.
Of note, 75 (88%) of the 85 investigated ESBL-EC isolates
showed resistance toward aminoglycoside gentamicin and
78 (92%) toward the sulfonamide-trimethoprim combination.
Eight isolates were ESBL-producers only, two isolates showed
resistance toward one further class of antimicrobials, 24 toward
two additional classes, 32 toward three additional classes and
3 toward antimicrobials belonging to four additional substance
classes (Table 1).
Unfortunately, three isolates were, by mistake, not stored
and were therefore not included in the further WGS-based
analysis process. Genes conferring β-lactam resistance and other
antimicrobial resistances (Supplementary Table 1) identified in
the remaining 82 whole genome sequences were in concordance
with the AST profiles (Supplementary Table 1). The most
predominate beta-lactam resistance gene identified in this study
was blaCTX−M−1 (n = 49), followed by blaCTX−M−15 (n = 13),
blaSHV−12 (n = 11), blaOXA−1 (n = 7) and blaCTX−M−14
(n = 5). One isolate carried blaCTX−M−3 (n = 1) and
the broadened β-lactam resistance was conferred by pAmpC
(blaCMY−2) in one case (Figure 3 and Supplementary Table 1).
Aminoglycoside resistance genes were most frequently associated
with ESBL-EC (74/82 genomes, 90%), especially aac (3) variants
(67 genomes, 82%), followed by genes enhancing resistance
toward sulfonamides (sul1 and/or sul2, 89%) and trimethoprim
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FIGURE 2 | Horses with ESBL-EC-positive specimens during hospital stay. Horses with ESBL-EC-positive specimens (nostril swabs and fecal samples) at t0
(hospital admission), t1 (3 days after surgery) and t2 (10 days after surgery). Since defecation disorders are frequently associated with colic syndrome, fecal samples
were not available for all horses at every time point. For the single-shot group (SSG), 32 horses met the criteria for participation in this study at t0 (A), with 31 nostril
swabs and 21 fecal available for the screening procedure. Of the 49 horses initially allotted to the 5-day group (5DG), 48 nostril swabs and 31 fecal samples were
collected at t0 (B). Due to the strict study design, specimens of horses failing the inclusion criteria in the ongoing study were excluded from further consideration at
t1 and/or t2, resulting in 27 participating horses for the SSG and 37 for the 5DG at t2. *, more than one isolate/specimen possible.
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TABLE 1 | AST profiles of ESBL-EC isolated from specimens of
hospitalized horses.
ST n ENR GEN SXT TET
10 12 ≤0.12 ≥16 ≥320 ≥16
1 ≤ 0.12 ≤1 ≤20 ≤1
2 1 ≥16 ≥320 ≤1
1 0.5 ≥16 ≥320 ≥16
1 0.5 ≥16 ≥320 ≤1
2 ≥4 ≥16 ≥320 ≥16
1,245 5 ≤0.12 ≥16 ≥320 =1
1,250 2 ≤0.12 ≥16 ≥320 ≤1
1 ≤0.12 ≥16 ≥320 =16
1 0.5 ≥16 ≥320 ≤1
1 ≤0.12 ≤1 ≥320 ≤1
224 5 ≥4 ≥16 ≥320 ≥16
410 3 ≥4 8 ≥320 =16
4 ≥4 ≥16 ≥320 ≥16
2 0.5 8 ≥320 ≥16
1 ≤0.12 ≤1 ≤20 ≤1
641 1 ≤0.12 ≥16 ≥320 ≤1
6 ≤0,12 ≥16 ≥320 ≥16
1 0.5 ≥16 ≥320 ≤1
1 ≥4 ≥16 ≥320 ≥16
86 2 1 ≥16 ≥320 ≥16
6 1 ≥16 ≥320 ≥16
155 2 ≤0.12 ≥16 ≥320 ≤1
1,686 1 ≤0.12 ≥16 ≥320 ≥16
1 1 =16 ≥320 ≤1
1,730 1 0.5 ≤1 ≤20 ≤1
1 1 ≤1 ≤20 ≤1
2,035 1 1 ≥16 ≥320 ≤1
2,325 1 1 ≤1 ≤20 ≤1
2,350 1 ≤0.12 ≥16 ≤20 ≤1
1 0.5 ≥16 ≥320 ≥16
617 3 ≥4 ≥16 ≥320 ≥16
648 1 ≥4 ≥16 ≥320 ≥16
6,589 1 0.5 ≥16 ≥320 ≤1
7,459 1 ≤0.12 ≤1 ≤20 ≤1
453 1 0.25 ≤1 ≤20 ≤1
973 1 ≤0.12 ≤1 ≤20 ≤1
NA 1 1 ≤1 ≥320 ≥16
Novel ST 1 1 ≥16 ≥320 ≥16
NA 1 ≤0.12 ≥16 ≥320 ≥16
1,204 1 1 ≥16 ≥320 ≤1
NA 1 0.5 ≥16 ≥320 ≤1
1,709 1 ≤0.12 ≥16 ≥320 =1
Antimicrobial susceptibility testing (AST) results of ESBL-producing E. coli. In order
to assess the importance of the AST profiles with respect to therapy options in
case of infection, plain numbers indicate susceptibility and bold ones a resistant
phenotype.
ST, sequence type; n, number of isolates; ENR, enrofloxacin; GEN, gentamicin;
SXT, trimethoprim-sulfamethoxazole; TET, tetracycline.
(dfrA and dfrG genes, 88%). More details on the distribution of
antimicrobial resistance genes in ESBL-EC isolates are provided




A phylogenetic tree was generated from 2,700 orthologs genes
identified using WGS data (Figure 3). Based on WGS analysis,
21 different STs were identified (Supplementary Table 1 and
Figure 3), including STs belonging to three dominating STC, i.e.,
STC10 (ST10; 23%), STC23 (ST410, 12%), and STC86 including
ST86 (10%), ST641 (11%), and ST453 (1.2%), revealing an
overall broad heterogeneity of phylogenetic backgrounds for the
ESBL/pAmpC-EC isolated in this study.
STs associated with isolates from only one study group
occurred rarely (e.g., ST453, n = 1, 5DG; ST617, n = 2, 5DG;
ST2035, n = 2, SSG; ST1709, n = 1, SSG), a detailed illustration
on the distribution of STs among the study groups is provided in
Figure 4.
Considering all ESBL-EC-positive nostril samples (n = 12;
5.5%), only one horse (54, Figure 3) was positive for ESBL-EC
ST10 blaCTX−M−1 twice (t1 and t2). The frequency of ESBL-
EC isolated from nostril swabs increased during hospitalization
(t0 = 1; t1 = 4, t2 = 7: comment: some swabs were positive for
more than one phenotype). The nostril swabs and fecal samples
of the horses with ID41 (t2, ST10 blaCTX−M−1) and ID69 (t2,
ST410 blaCTX−M−15) were positive for the same ESBL-EC clone
(Figure 5). Contrary, the clonal background of the nostril/fecal
isolates of horses with the IDs 20 (t2: ST10 blaCTX−M−1/ST1245
blaCTX−M−14), 49 (t2: ST10 blaCTX−M−1/ST155 blaCTX−M−1),
and 78 (t2: ST-224 blaCTX−M−1/ST641 blaCTX−M−1) were
different (Supplementary Table 1).
Overall, fecal samples collected from 18 horses (n = 7 from
the SSG and n = 11 from the 5DG) were ESBL-EC positive at two
different time-points (t1 and t2). In two cases, isolates from t1 and
t2 differed by two SNPs (5DG, ID26, ST617 blaCTX−M−15 and
5DG, ID58, ST86 blaSHV−12) and were therefore considered as
the same clone, respectively.
While all ST86 ESBL-EC were associated with blaSHV−12,
distantly related ST1730 isolates were positive for blaSHV−12
as well. Further associations were obvious for blaCTX−M−14
with ST1245, while blaCTX−M−15 was identified in various
clonal backgrounds (ST617, ST973, ST410, ST648, and ST2325)
(Supplementary Table 1). Likewise, blaCTX−M−1 was distributed
across multiple genomic lineages (Supplementary Table 1).
In silico detection of plasmid replicons revealed variation for the
number of replicons associated with the isolates as well as a broad
range of different replicon types, including IncFIA/B and IncFII
(Supplementary Table 1).
Spatio-Temporal Dynamics of ESBL-EC
Since we noticed an increase of ESBL-EC isolation rates in
specimens of horses belonging to both study groups during
hospital stay, questions concerning spatio-temporal dynamics
and persistence of distinct genomic lineages within the clinic
(Figures 3, 4) have been raised. A scatter plot displaying SNP
distances, calculated for the ESBL-EC genomes of those isolates
belonging to the predominating STCs, was used to further
investigate the suspected local spreads.
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FIGURE 3 | Core-genome based phylogeny of 82 equine ESBL-EC isolated from hospitalized horses subjected to colic surgery. Maximum likelihood phylogenetic
tree generated with RAxML and visualized using the CLC Genomics Workbench based on 2,700 orthologous genes from 82 ESBL-EC WGS. Sequence type
(MLST), sampling day (t0, t1, or t2), individual horses (ID), sampling date, sampling site (source) and study group (SSG or 5DG) are indicated.
The illustration shows the time of hospital admission and the
study group assignment for individual horses. ESBL-EC-positive
samples at t0, t1, and t2 and close phylogenetic relationships with
isolates obtained from specimens of other horses (Figures 5A–
C) are indicated. The fecal sample of horse 5, for instance, was
positive for an ST10 ESBL-EC at t2 with no recent history (i.e.,
t0, t1) of ESBL-positive specimens in our study (Figure 5A).
In addition, an indistinguishable clone was identified in the t2-
sample of horse 4, a horse which also had no ESBL-positive
specimens before (Supplementary Table 1). Since the next
ST10 ESBL-EC genome included here differed by at least 5,982
SNPs (Supplementary Figure 1), a common source of both
isolates such as other (hospitalized) horses and/or the hospital
environment seems likely, especially considering their close
temporal relationship (Figure 5A).
Several additional close spatio-temporal relationships of
ST10 ESBL-EC genomes are shown in Figure 5A. While
there were “genomic singletons,” e.g., from samples of the
horses 26 and 49, many further genomes were classified
as closely related (Supplementary Figures 1–3), including
indistinguishable genomes for isolates of the equine patients
41 and 43 (0 SNP difference); horse 54 and 59 (1 SNP
difference) as well as horse 59 and 63 (2 SNP difference)
and horse 64 and 72 (2 SNP difference). Considering isolation
dates for isolates belonging to STC86, a direct or indirect
link most likely exists between ST641 ESBL-EC obtained from
fecal samples of horse 31 (t1) and 35 (t2). Moreover, a total
of 7 closely related genomes (0–3 SNP difference) have been
identified for ESBL-EC from specimens of horses hospitalized
between 9/2018 and 9/2019 (Figure 5B and Supplementary
Figure 2). A further cluster comprised 9 ST86 ESBL-EC from
8 horses, including 5 indistinguishable (0 SNP difference)
genomes (Figure 5B). It should be noted that none of these
horses were associated with an STC86 ESBL-EC specimen
at hospital admission (Figure 5B). A cluster of 8 closely
related (0–2 SNP difference) ST410 ESBL-EC genomes (STC23)
was identified for specimens from 6 horses hospitalized in
July and August 2019 (Figure 5C), once more strongly
indicating a local and temporary spread and transmission of this
particular clone as well.
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FIGURE 4 | Occurrence and distribution of sequence types associated with equine ESBL-EC. Each colored square indicates an ESBL-EC, isolates of the SSG are
represented in green and those from samples of the 5DG are blue. Sampling time points are indicated by different shades of gray and column headings.
DISCUSSION
This study showed that the proportion of fecal samples positive
for ESBL-EC increases among hospitalized horses subjected
to median laparotomy. It further provided evidence for the
local spread of distinct MDR ESBL-EC clones and the local
predominance of isolates belonging to ST10, STC86 and ST641
backgrounds. While the original intention of the present
study was to comparatively investigate the particular influence
of a short versus a prolonged P/G PAP regime on ESBL-
EC isolation rates, the overwhelming effect of hospitalization
seems to outmatch the (putative) differences between distinct
P/G PAP courses.
Isolation Rates of ESBL- EC in
Specimens of Equine Patients
Caution is always needed when comparing study results
with respect to study designs, population characteristics, local
circumstances and methodical protocols used for ESBL (and
pAmpC)-EC detection. In the present study, the observed ESBL-
EC rates for fecal samples collected at hospital admission ranged
from 5% (SSG) to 10% (5DG). Detected rates are in general
concordance with previous studies, reporting proportions from
7 to 16% (Maddox et al., 2012; Walther et al., 2018b;
Schoster et al., 2020), but lower than in studies using selective
enrichment (Shnaiderman-Torban et al., 2020). A very recent
study by Schoster et al. (2020) on hospitalized horses shedding
ESBL-EC included different groups of equine patients while the
duration of the PAP or anti-infective antimicrobial courses was
determined individually for each patient by the veterinarian
in charge. The fecal samples were collected -amongst other
times- at hospital admission and 48–60 h afterward (Schoster
et al., 2020). Interestingly, Schoster et al. (2020) found no
significant difference concerning the ESBL-EC shedding rates
in horses receiving either a fourth-generation cephalosporin
or the common P/G combination. Although neither the study
design nor the study population included by that particular
work are directly comparable with the present study, interesting
similarities are apparent: An increase in ESBL-EC detection
rates reported for samples of hospitalized horses, for instance,
are clearly in line with those recorded in the present study,
since they have also noted an elevation in detection rates
beyond 50% within 3 days after hospital admission. Schoster
et al. (2020) also reported that the ESBL-EC isolation rates
increased from 6.9 to 36% within 3 days after admission in
horses which received no antibiotics at all. Consequently, a
direct and overwhelming influence of hospitalization on the
actual detection rate for samples from equine patients seems
reasonable, probably also masking the effects of different P/G
PAP regimes in the present study. However, since the ESBL-
EC detection was lower in fecal samples obtained from the
SSG, especially at t1 (Figure 2), a beneficial effect of less
selective pressure associated with the short-term P/G PAP
regime seems likely. Nonetheless, due to the limited number of
study participants, the difference lacked statistical significance.
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FIGURE 5 | Local spread of distinct ESBL-EC. The illustrations (A–C) show scatter plots displaying SNP distances calculated for the most prevalent ESBL-EC
lineages on a time scale. In order to assess the possible phylogenetic and temporal relationships between the isolates, isolates of each horse (indicated by its
identification number (ID)) share a particular color. Isolates gained from nostril swabs are indicated by circles, fecal isolates by triangles. The number of SNPs
between two isolates is marked with a specific line. (A) Shows all isolates belonging to ST10; (B) STC86 (ST641 and ST86); and (C) ST410.
A recent study on non-hospitalized horses identified antibiotic
treatment and veterinary examinations as risk factors associated
with ESBL-EC carriage (Kaspar et al., 2019). Further studies
on the subject are clearly needed, especially since antimicrobial
consumption was reported being among the most important
risk factors for ESBL-EC colonization in human medicine
(Harris et al., 2007).
One might argue that, if a single location is not sufficient
to provide robust numbers of study participants, including
additional clinics might enhance the study power. On the
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other hand, as recently shown by various authors, the local
MDR burden tends to differ, especially during hospitalization
(Apostolakos et al., 2017; Isgren et al., 2019; Hordijk et al., 2020;
Shnaiderman-Torban et al., 2020), indicating a potential source
of bias when considering multicenter studies. In addition, it
seems likely that technical, structural and hygiene circumstances
differ between facilities providing health care for horses, since
overall comparability of standards, to the best of the authors’
knowledge, has not been achieved yet.
Antibiotic Susceptibility Profiles and
Antimicrobial Resistance Genes
In this study, the predominating ESBL-genes were blaCTX−M−1
(59.7%) and blaCTX−M−15 (15.8%), which supports earlier
findings (Lupo et al., 2018; Walther et al., 2018b; Isgren et al.,
2019; Hordijk et al., 2020).
Most of the isolates investigated in this study showed not
only broadened resistance associated with their β-lactam
resistance but also reduced susceptibility to other antimicrobial
substances as well: Most of the ESBL-EC (51/85; 60%) isolates
fulfilled the criteria for MDR (Schwarz et al., 2010). These
MDR ESBL-EC pose therapeutic challenges for veterinarians
since resistance genes conferring resistance to aminoglycosides,
tetracyclines and trimethoprim/sulfamethoxazole are often
present on the same plasmid (Li et al., 2019). Since the
panel of antimicrobial substances currently available for
approved administration to horses is very limited and includes
the above mentioned antimicrobials (Maddox et al., 2012;
Walther et al., 2014a), targeted strategies and guidelines
are needed to cope with the apparent clinical challenges in
equine antimicrobial therapy, especially to prevent hospital-
associated infections and to reduce potential transmission
between different sources and hosts, including humans (Walther
et al., 2014b; Apostolakos et al., 2017; Royden et al., 2019;
Hordijk et al., 2020).
Phylogenetic Background of ESBL-EC
Isolated From Samples of Hospitalized
Horses
In total, 21 different STs have been identified for the ESBL-EC and
the single pAmpC-EC, confirming earlier studies which reported
a broad heterogeneity of phylogenetic backgrounds for ESBL-
EC in horses (Apostolakos et al., 2017; Walther et al., 2018b;
Schoster et al., 2020). Different ESBL-EC have been detected in
a single sample, e.g., ESBL-EC belonging to ST10 and ST1245
in the “t2 fecal sample” of horse 20 (Supplementary Table 1).
Hence, including different phenotypes in the ESBL-EC screening
process is mandatory, as previously reported by Apostolakos et al.
(2017). Considering the occurrence and broad distribution of STs
among the isolate collection investigated (Figure 4), no obvious
differences were identified.
However, ST10, STC86 (ST86, ST641, and ST453) and ST410
were the predominating phylogenetic lineages associated with the
isolate collection, and assessment of their genomic relatedness
revealed a close relationship (based on SNP differences) between
many of the isolates belonging to a particular ST. Of note, neither
ST86 nor ST641 were found to be associated with ESCL-EC
isolated from specimens taken at hospital admission (Figure 5B).
Consequently, a common source and/or direct or indirect
transmission of these ESBL-EC (Figure 3) seems more likely
than spread of certain plasmids carrying β-lactam resistance
genes, as previously suggested (Walther et al., 2018b). This
hypothesis is supported by the finding that the overall diversity
of genetic backgrounds seems to have decreased over time: while
18 different STs were associated with the 35 isolates obtained at
t1, the 45 isolates representing t2 belonged to only 12 different
STs, with ST10 (12 isolates), ST641 (8 isolates), and ST410 (6
isolates) being dominating lineages. Moreover, previous reports
from Germany, the Netherlands and the United Kingdom also
described ESBL-EC belonging to ST10, STC86, and ST410 for
samples of horse origin as among the predominating lineages
(Apostolakos et al., 2017; Walther et al., 2018b; Bortolami et al.,
2019; Schoster et al., 2020).
Of note, MDR ESBL-EC belonging to ST10 were only recently
reported for samples of meat, poultry and wildlife origin as well as
for clinical human samples in Spain, once more emphasizing that
this lineage is able to adapt to different life circumstances while
crossing the borders of different niches and hosts (Diaz-Jimenez
et al., 2020). Similar to the ubiquitous occurrence of E. coli-ST10,
E. coli belonging to ST410 have also been described for samples
from various hosts, including companion animals, livestock
animals, wildlife- and human samples (Falgenhauer et al., 2016;
Fischer et al., 2017; Reynolds et al., 2019). Moreover, ST410
was previously described as a genomic lineage containing high-
risk trans-sectoral transmissible and multidrug-resistant clones
in veterinary as well as human medicine (Schaufler et al., 2016;
Roer et al., 2018). A recent study by Touchon et al. (2020) found
that phylogeny and habitat shape the genetic diversification
of E. coli to similar extents, and diversification might occur
by acquiring genes and mobile elements not only from other
gut-residing bacteria but from (well-established) environmental
bacteria as well.
Spatio-Temporal Dynamics of ESBL-EC
During Hospitalization
Considering the nostril swabs that were occasionally found
positive for ESBL-EC, we detected the same clone (0–2 SNPs
difference) in fecal samples as well, e.g., for horse 69 (t2;
ST-410 blaCTX-M-15) or horse 41 (t2, ST10 blaCTX-M-1).
On the other hand, we also identified a single clone (ST86
blaSHV−12) in nostril swabs of two distinct horses (t1, horse 66
and 68), (for details see Supplementary Table 1 and Figures 5A–
C). Previous studies which included environmental sampling
identified ESBL-EC contamination of horse stables, the floor,
medical equipment and other sites as a possible source for in-ho
transmission (Walther et al., 2014b; Schoster et al., 2020). While
the detection of ESBL-EC in nostril swabs screened at hospital
admission was assumed to represent prior contamination, for
instance associated with nasogastric intubation (Walther et al.,
2018b), sampling results presented here point toward a direct
or indirect transmission during hospitalization. These results
are in concordance with previous research revealing veterinary
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clinics as “hotspots” for transmission of MDR Enterobacterales
(Wright et al., 2005; Apostolakos et al., 2017; Walther et al.,
2018b). Some closely related isolates were able to spread over
several months-for example, in the period from January to
August 2019 (STC10 and STC86). Last but not least, contact with
horses was previously identified as a risk factor for humans to
become colonized by ESBL-producing bacteria (Huijbers et al.,
2013). Since our results are in line with recent reports from
other horse clinics, we are confident that local accumulation and
spread together with the presence of vulnerable patients receiving
antibiotics and other selective agents are the main drivers for
the presented observations. Therefore, increasing awareness for
the importance of hygiene is necessary to cope with the current
challenges presented by MDR and zoonotic pathogens in horse
clinics: As a direct consequence of our study results, hygiene
recommendations for horse clinics have been recently published
(Gehlen et al., 2020).
CONCLUSION
MDR pathogen accumulation in horse clinics, including ESBL-
EC, is a threat to both, the equine patients and the people working
with and around them. Considering the proverb “an ounce of
prevention is worth a pound of cure,” the time to critically re-
consider hygiene recommendations and common protocols for
the administration of antibiotics in equine medicine appears
overdue, especially if prolonged antibiotic courses seem to lack
scientific proof of superior outcomes in patients, which needs to
be addressed thoroughly in further studies.
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